These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 345516)

  • 1. [3-year treatment of hypercholesteremia with clofibrate under conditions of double-blind method].
    Metelitsa VI; Dokuchaeva EA; Chubukova AL; Iliushina IP; Ostrovskaia TP
    Ter Arkh; 1978; 50(1):45-50. PubMed ID: 345516
    [No Abstract]   [Full Text] [Related]  

  • 2. The clofibrate trial--the lipid hypothesis retested.
    Med J Aust; 1979 Jun; 1(11):490-1. PubMed ID: 381862
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etofibrate and clofibrate in double blind study].
    Rahlfs VW; Zimmermann H; Safer A
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1168-9. PubMed ID: 789039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a new drug association on hypercholesteremia studied with a controlled clinical trial].
    Manaresi A
    Clin Ter; 1971 Mar; 56(6):523-34. PubMed ID: 5131092
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofibrate: a final verdict?
    Lancet; 1978 Nov; 2(8100):1131-2. PubMed ID: 82687
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increased mortality with clofibrate].
    Wedel H; Vedin A; Wilhelmsen L
    Lakartidningen; 1979 Jan; 76(5):273-4. PubMed ID: 366304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
    Gavelli MS; Vitaliano E; Serra T; Rossi FG; Rizzuti A; Caridis R; Tozzi J
    Clin Ter; 1990 May; 133(3):145-50. PubMed ID: 2142901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to treatment and health outcomes.
    Horwitz RI; Horwitz SM
    Arch Intern Med; 1993 Aug; 153(16):1863-8. PubMed ID: 8250647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
    de Gennes JL
    Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186
    [No Abstract]   [Full Text] [Related]  

  • 14. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
    Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study (author's transl)].
    Lindenbaum A; Hernandorena X; Vial M; Benattar C; Janaud JC; Dehan M; Foliot A; Leluc R; Gabilan JC
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():867-73. PubMed ID: 7036932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb].
    Kokot F; Szczechowska E
    Z Gesamte Inn Med; 1981 Jul; 36(13):454-7. PubMed ID: 7025475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a new lipid-reducing preparation (Etofibrat) on hyperlipoproteinemia type II. 2].
    Knüchel F
    Med Welt; 1974 Nov; 25(44):1810-2. PubMed ID: 4372508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
    Guarini G; Costa C; Trimarco C; Santese D; Vitaliano E
    Clin Ter; 1988 Apr; 125(1):41-50. PubMed ID: 2974357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.